You are here

Home » Content

Aile Hekimliği polikliniğinde multiple myeloma tanısı almış bir olgu

A case diagnosed as multiple myeloma on a Family Medicine policlinic

Journal Name:

  • Smyrna Tıp Dergisi

Publication Year:

  • 2011

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Multiple myeloma is a disease characterized by the increase of plasma cells and abnormal production of immunoglobulins properly in bone mellow and sporadicaly in other organs and systems. In this case report, an outpatient addressing to the family medicine policlinic of Ordu University Education and Research Hospital, with joint pains, fever, cough, weakness and loss of weight is narrated. By courtesy of this case, the addressing of patients with several diseases to the Family Medicine policlinics is emphasized.
Bookmark/Search this post with
Abstract (Original Language): 
Multiple Myeloma plazma hücrelerinin başlıca kemik iliğinde, nadiren de diğer organ ve sistemlerde artışı ve anormal immunoglobulin üretimi ile karakterli bir hastalıktır. Bu olgu sunumunda, Ordu Üniversitesi Eğitim ve Araştırma Hastanesi Aile Hekimliği polikliniğine eklem ağrıları, ateş, öksürük, halsizlik ve kilo kaybı şikayetleriyle başvuran ve multiple myeloma tanısı alan bir hasta tartışılmıştır. Bu vaka ile Aile Hekimliği polikliniklerine farklı hasta gruplarının başvurabileceğine dikkat çekilmeğe çalışılmıştır.
FULL TEXT (PDF): 
PDF icon arastirmax-aile-hekimligi-polikliniginde-multiple-myeloma-tanisi-almis-bir-olgu.pdf
  • 1
46-48
  • Turkish

REFERENCES

References: 

1. Coşkun S, Er Ö, İlhan O. Multiple Myeloma: Güncel
Yaklaşımlar. Erciyes Tıp Dergisi 2001; 23(2):83-90.
2. Bataille R, Jean-Luc Harousseau JL. Multiple
myeloma. N Eng J Med 1997; 336:1657-1664.
3. Özet A, Pınar B. Multiple Myelomada Yüksek Doz
Kemoterapi. Türkiye Klinikleri Hematoloji Dergisi
2003;1,1.
4. Çağırgan S, Vural F. Multiple Myelomda
Hematopoetik Kök Hücre Transplantasyonu. Türkiye
Klinikleri Hematoloji - Onkoloji Özel Dergisi.
2008;1:29-34.
5. Bersagel D. The Incidence and epidemiyology of
plasma cell neoplasms. Stem Cells 1995; 13(Suppl2):
1-9.
6. Çağırgan S, Pehlivan M, Dönmez A. Autoloous
Peripheral Blood Hematopoietic stemö Cell
Transplantation In Newly Diagnosed Multiple
Myeloma Patient. Ege Tıp Dergisi 2003; 42(3): 167-
172.
7. Mc Ewain TJ, Po Wles RJ. High dose intravenous
melphalan for plasma cell leukemia and myeloma.
Lancet 1983; 2:822-824.
8. Jagannath S, Barlogie B. Autologous bone marrow
transplantation for multiple myeloma. Hematol Oncol
Clin North Am 1992; 6:437-449.
9. GratWohl A, Baldomero H, PassWeg J for the
Accredition Committe of the European Group for
Blood and Marrow Transplantation. Hematopoietic
stem cell transplantation for hematological
malignancies in Europea. Leukemia 2003; 17:941-
959.
10. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet
JB, Rossi JF et al. A prospective, randomised trial of
autologous bone marrow transplantation and
chemotherapy in multiple myeloma. N Eng J Med
1996; 335:91-97.
11. Selby P, Child T, Davies FE, Hawkins K, Brown J,
Bell S et al. The MRC Myeloma VII Trial of Standard
versus intensive treatment in patients <65 years of age
with multiple myeloma. Brit J Cancer 2002; 86:S1.
12. Urbano-Ispizua A, Schmitz N, de Witte T for
European Group for Blood and Marrow
Transplantation. Allogenic and autologous
transplantation for haematological diseases, solid
tumours and immune disorders: definitions and
current practice in Europe. Bone Marrow Transplant
2002; 29:639-646.
İletişim:
Uz.Dr. Özgür ENGİNYURT
Ordu Üniversitesi Eğitim ve Araştırma Hastanesi
Aile Hekimliği Birimi Ordu/Türkiye
tel: +90.532.2317499
mail: enginyurt72@gmail.com

Thank you for copying data from http://www.arastirmax.com